Adaptive Biotechnologies (ADPT) News Today → Does this chart look familiar? (From InvestorPlace) (Ad) Free ADPT Stock Alerts $3.80 +0.30 (+8.57%) (As of 05/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 10 at 5:26 AM | americanbankingnews.comHead-To-Head Survey: Replimune Group (NASDAQ:REPL) vs. Adaptive Biotechnologies (NASDAQ:ADPT)May 9, 2024 | finance.yahoo.comAdaptive Biotechnologies First Quarter 2024 Earnings: Beats ExpectationsMay 9, 2024 | americanbankingnews.comAdaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Up Following Strong EarningsMay 9, 2024 | msn.comAdaptive Surf Championships return to Waikiki welcoming athletes from 18 countriesMay 8, 2024 | fool.comWhy Adaptive Biotechnologies Topped the Market TodayMay 8, 2024 | finance.yahoo.comAdaptive Biotechnologies Corporation (NASDAQ:ADPT) Q1 2024 Earnings Call TranscriptMay 8, 2024 | marketbeat.comAdaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Up Following Earnings BeatAdaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Up on Earnings BeatMay 8, 2024 | marketbeat.comAdaptive Biotechnologies (NASDAQ:ADPT) Issues Quarterly Earnings ResultsAdaptive Biotechnologies (NASDAQ:ADPT - Get Free Report) posted its earnings results on Tuesday. The company reported ($0.33) earnings per share for the quarter, beating analysts' consensus estimates of ($0.35) by $0.02. The company had revenue of $41.87 million for the quarter, compared to analyst estimates of $38.78 million. Adaptive Biotechnologies had a negative return on equity of 53.65% and a negative net margin of 132.29%. The company's revenue for the quarter was up 11.2% on a year-over-year basis. During the same quarter last year, the company earned ($0.40) earnings per share.May 8, 2024 | finance.yahoo.comAdaptive Biotechnologies Corp (ADPT) Q1 2024 Earnings Call Transcript Highlights: Strategic ...May 8, 2024 | msn.comADPT Stock Earnings: Adaptive Biotechnologies Beats EPS, Beats Revenue for Q1 2024May 7, 2024 | seekingalpha.comAdaptive Biotechnologies Corporation 2024 Q1 - Results - Earnings Call PresentationMay 7, 2024 | finance.yahoo.comAdaptive Biotechnologies: Q1 Earnings SnapshotMay 7, 2024 | markets.businessinsider.comAdaptive Biotechnologies Q1 Loss decreases, beats estimatesMay 7, 2024 | finance.yahoo.comAdaptive Biotechnologies Q1 2024 Earnings: Revenue Beats Estimates Amidst ChallengesMay 7, 2024 | globenewswire.comAdaptive Biotechnologies Reports First Quarter 2024 Financial ResultsMay 5, 2024 | americanbankingnews.comAdaptive Biotechnologies (ADPT) Set to Announce Earnings on TuesdayMay 1, 2024 | tmcnet.comHITRUST Enhances Cyber Threat Adaptive Engine Using Microsoft Azure OpenAI Service and Microsoft Defender Threat IntelligenceMay 1, 2024 | finance.yahoo.comNetenrich Launches Adaptive MDR™ for Google Chronicle Security Operations, Powered by Resolution Intelligence Cloud™ TechnologyApril 30, 2024 | msn.comUniversity of Arizona Adaptive Athletic Department receives $1 million donationApril 28, 2024 | marketbeat.comabrdn plc Invests $4.58 Million in Adaptive Biotechnologies Co. (NASDAQ:ADPT)abrdn plc purchased a new position in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 933,794 shares of the company's stock, valApril 24, 2024 | msn.comFizik Antares Adaptive Reshapes Saddle that Started Fizik’s 3D-Printed Padding BoomApril 24, 2024 | finance.yahoo.comAdaptive Shield Launches Fast Forward Partner Program to Help Enterprises Secure the SaaS EcosystemApril 17, 2024 | globenewswire.comAdaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024April 16, 2024 | bizjournals.comAdaptive Biotechnologies names new CFO, restructures business linesApril 15, 2024 | marketbeat.comAdaptive Biotechnologies Co. (NASDAQ:ADPT) Short Interest UpdateAdaptive Biotechnologies Co. (NASDAQ:ADPT - Get Free Report) was the target of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 9,100,000 shares, a growth of 7.6% from the March 15th total of 8,460,000 shares. Approximately 6.6% of the company's stock are short sold. Based on an average daily volume of 1,490,000 shares, the days-to-cover ratio is currently 6.1 days.April 13, 2024 | msn.comAdaptive Foundation offers free fitness classes for veterans, first responders in TylerApril 9, 2024 | msn.comThe Center for Adaptive Riding hosts open house for new locationApril 4, 2024 | marketbeat.comAdaptive Biotechnologies Co. (NASDAQ:ADPT) Given Average Rating of "Moderate Buy" by AnalystsAdaptive Biotechnologies Co. (NASDAQ:ADPT - Get Free Report) has received an average rating of "Moderate Buy" from the five brokerages that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating and three have given a buy rating tApril 4, 2024 | marketbeat.comAdaptive Biotechnologies (NASDAQ:ADPT) PT Lowered to $5.00 at BTIG ResearchBTIG Research lowered their target price on Adaptive Biotechnologies from $6.00 to $5.00 and set a "buy" rating for the company in a report on Thursday.April 4, 2024 | uk.investing.comAdaptive Biotechnologies CFO resigns, successor namedApril 2, 2024 | marketwatch.comAdaptive Biotechnologies to Restructure Businesses After ReviewApril 2, 2024 | globenewswire.comAdaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 RevenueApril 1, 2024 | msn.comCenter for Adaptive Riding hosts open house at new facilityMarch 30, 2024 | msn.comLocal family hosts ‘Adaptive Easter Egg Hunt’March 28, 2024 | finance.yahoo.comNetcracker Continues Its Support of the U.S. Paralympic Ski and Snowboard Team at Adaptive Spirit 2024March 28, 2024 | marketbeat.comARK Investment Management LLC Boosts Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT)ARK Investment Management LLC raised its stake in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 11.3% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 12,806,513 shares of the company'March 27, 2024 | investorplace.comThe 7 Best Penny Stocks to Buy in Q2 2024March 27, 2024 | globenewswire.comAdaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024March 27, 2024 | finance.yahoo.comCanada Adaptive Clothing Market to Reach US$ 79.08 Million by 2031, Rising at a CAGR of 8.7% | Report by CoherentMIMarch 23, 2024 | msn.comAdaptive surfers dazzle at Byron Bay as they push for acceptance into ParalympicsMarch 19, 2024 | finance.yahoo.comTeam behind popular Falcon AI models unveils new startup with $20 million in funding aimed at helping companies tailor LLMs for businessMarch 16, 2024 | forbes.comXBox Adaptive Controller Review: A Necessary AccessoryMarch 16, 2024 | insidertrades.comAdaptive Biotechnologies Co. (NASDAQ:ADPT) Insider Sells $26,503.61 in StockMarch 12, 2024 | sports.yahoo.comAre algorithms going to revolutionize MTB suspension? RockShox releases new Flight Attendant with Adaptive Ride DynamicsMarch 12, 2024 | marketbeat.comAdaptive Biotechnologies (NASDAQ:ADPT) Stock Price Down 4.2%Adaptive Biotechnologies (NASDAQ:ADPT) Trading Down 4.2%March 12, 2024 | tmcnet.comAdaptive ML Raises $20M to Help Companies Build Unique GenAI ExperiencesMarch 11, 2024 | marketbeat.comAdaptive Biotechnologies (NASDAQ:ADPT) Trading Up 7.4%Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Up 7.4%March 10, 2024 | msn.comBoston-based film ‘American Fiction’ wins Oscar for Best Adaptive ScreenplayMarch 6, 2024 | msn.comAdaptive Adventures returns to MarquetteMarch 5, 2024 | marketbeat.comAdaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Down to $3.99Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Down to $3.99 Get Adaptive Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ADPT and its competitors with MarketBeat's FREE daily newsletter. Email Address The A.I. story nobody is telling you (Read ASAP) (Ad)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about... Click here to see Louis' new video for yourself. ADPT Media Mentions By Week ADPT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADPT News Sentiment▼0.360.58▲Average Medical News Sentiment ADPT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADPT Articles This Week▼193▲ADPT Articles Average Week Get Adaptive Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ADPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Taysha Gene Therapies News Today Editas Medicine News Today C4 Therapeutics News Today iTeos Therapeutics News Today Lexeo Therapeutics News Today Fate Therapeutics News Today Voyager Therapeutics News Today Alvotech News Today Replimune Group News Today Allogene Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADPT) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptive Biotechnologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
